不良事件报告

如果发生不良事件,患者应始终寻求医生或药剂师的建议。

如果您想向ELC Group s.r.o.报告不良事件,请在下面找到联系信息:

+420 224 910 672

(欧洲中部时间09.00-17.30)

+420 226 251 459

(24/7不间断)

有关其他任何问题,请与我们联系:

+420 22 491 0000或我们的 区域办事处。

Hlášení nežádoucích príhod

Pacienti by meli vždy požádat o radu svého lékare nebo lékárníka v prípade výskytu nežádoucích príhod.

Pokud chcete nahlásit nežádoucí príhodu spolecnosti ELC Group s r.o., prosím využijte kontaktních údaju níže:

+420 224 910 672

(09.00-17.30 CET)

+420 226 251 459

(non-stop 24/7)

Pro záležitosti, které se netýkaji farmakovigilance, kontaktujte prosím recepci:

+420 22 491 0000 nebo naše další pobočky.

ELC Group Appoints Head of Regulatory Affairs for Russia and CIS

Inna Demidova to head new Moscow office for fast-growing global regulatory affairs specialist

Cambridge, UK, 28 July, 2014 – ELC Group, one of the fastest-growing providers of regulatory affairs, today announces the appointment of Inna Demidova as a Senior Regulatory Affairs Expert for Russia and the Commonwealth of Independent States (CIS).

Previously with Ferring Pharmaceuticals as Regulatory Affairs Manager, Inna Demidova is an expert on both the Russian and CIS regulatory environment and clinical trials organisations, having managed numerous teams through rigorous registration, QA and medical activities. Inna Demidova will also be tasked with heading ELC Group’s planned Moscow office, due to open later in 2014.

The establishment of a regional base in Russia comes off the back of a record year of growth and revenue performance for ELC Group, with office openings in Brazil and China set to follow soon.

Commenting on the appointment, ELC Group’s CEO Marco Rubenstein said: “We are very pleased to welcome Inna to the ELC Group team. Her knowledge and experience of the Russian and CIS territories is extremely impressive and we look forward to rapidly expanding our presence under her expert guidance.”

Inna Demidova added:

“I am very excited to be joining ELC Group as Head of Regulatory Affairs for Russia and CIS, and to bringing ELC Group’s market-leading services to these crucial markets.”

Inna Demidova studied Pharmacology at Medical State University in Almaty, Kazakhstan, before later receiving a Bachelor of Science from Portland Business College.

相关新闻